Company / CapEx per Share
PALVELLA THERAPEUTICS, INC. CapEx per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2023
5-year range
$0.00 / $0.05
FY2019-FY2023
Trend
-84.1%
vs FY2022
Sector context
#160 of 192
Health Care
What the data says
PALVELLA THERAPEUTICS, INC.'s capex per share of $0.00 is lower than 83% of companies in the Health Care sector (FY2023). CapEx per Share has fluctuated over the past 9 years, ranging from $0.00 in FY2023 to $0.05 in FY2021.
Based on SEC 10-K filings.
0.00 in FY2023 with a 5-year CAGR of -44.4%.
Declined from $0.05 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -62.8%
- 5-Year CAGR
- -44.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 192This company $0.00 Sector average $2.46
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2023, capex per share decreased 84.1% year-over-year.
- Ranks #160 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0.00 | -84.1% |
| FY2022 | $0.01 | -70.4% |
| FY2021 | $0.05 | +9.2% |
| FY2020 | $0.04 | -1.9% |
| FY2019 | $0.05 | +5.0% |
| FY2018 | $0.04 | +233.1% |
| FY2017 | $0.01 | -7.5% |
| FY2016 | $0.01 | -68.6% |
| FY2015 | $0.04 | +98.1% |
As of FY2023 · SEC 10-K Annual Filings · Updated Jun 30, 2026